(Q34764715)

4 August 2017

1 reference

title

NKT cells: potential targets for autoimmune disease therapy? (English)

1 reference

4 August 2017

1 reference

Hammond KJ

1

1 reference

4 August 2017

Godfrey DI

series ordinal

2

1 reference

4 August 2017

publication date

1 May 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

59

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

353-363

1 reference

Mouse CD1-specific NK1 T cells: development, specificity, and function

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

NKT cells: facts, functions and fallacies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

NKT cells - conductors of tumor immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Autoreactivity by design: innate B and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8- thymocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Genetic models for CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimm

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Clinical application of NKT cell assays to the prediction of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

Diverse CD1d-restricted reactivity patterns of human T cells bearing “invariant” AV24BV11 TCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

CD1d-Restricted NKT Cells: An Interstrain Comparison

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

MIP-2 recruits NKT cells to the spleen during tolerance induction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

NKT cells and tumor immunity—a double-edged sword

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

A molecular analysis of NKT cells: identification of a class-I restricted T cell-associated molecule (CRTAM)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Multiple immuno-regulatory defects in type-1 diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Increased interleukin-4 production by NK T cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Decreased TCR AV24AJ18+ double-negative T cells in rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590501.X

7 January 2021

10.1034/J.1399-0039.2002.590501.X

Identifiers

DOI

1 reference

4 August 2017

1 reference